Company Filing History:
Years Active: 2025
Title: Lourdes Palacios: Innovator in Mitochondrial Nucleic Acid Research
Introduction
Lourdes Palacios, an accomplished inventor located in Derio, Spain, has made significant contributions to the field of biological research. With a focus on mitochondrial nucleic acid depletion and detection, her innovative methods have the potential to advance scientific understanding and diagnostic techniques.
Latest Patents
Lourdes Palacios holds a patent titled "Mitochondrial Nucleic Acid Depletion and Detection." This invention provides a method for depleting host nucleic acid in a biological sample obtained from an animal host. The method involves treatments to lyse host cells and subsequently deplete or render unidentifiable the nucleic acids released from these cells. The patented process includes steps for depleting host mitochondria or mitochondrial DNA (mtDNA) and for extracting and analyzing the remaining nucleic acids. Additionally, the patent describes a related kit containing reagents necessary for performing the method, as well as a technique for isolating mitochondrial DNA post-lysis of host cells.
Career Highlights
Throughout her career, Lourdes Palacios has worked with esteemed companies, including Progenika Biopharma S.A. and UEA Enterprises Limited. Her roles in these organizations have been pivotal in progressing her research endeavors and in collaborating on significant projects that impact the field of biotechnology.
Collaborations
In her professional journey, Lourdes has had the opportunity to collaborate with notable colleagues such as Nerea Bartolome and Antonio Martinez. These partnerships have contributed to her innovative projects and the successful execution of her research methodologies.
Conclusion
Lourdes Palacios exemplifies the spirit of innovation in the scientific community. Her singular patent highlights a crucial advancement in the techniques used to analyze biological samples, potentially transforming how researchers and medical professionals work with mitochondrial DNA. With her expertise and collaborative efforts, Lourdes continues to pave the way for future innovations in the realm of biotechnology.